TFEB and renal cell adenocarcinoma: In the WHO 2016 classification (4th edition), transcription factor binding to IGHM enhancer 3 (TFE3)-rearranged RCC and transcription factor EB (TFEB)-rearranged RCC were grouped under the 'MIT family RCC' category.